MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2: Erratum

Xuemei Yang, Jialing Sun, Haitao Sun, Bin Wen, MingJia Zhang, HaiYan An, Weicong Chen, Wenting Zhao, Xiaodan Zhong, Chunyu He, Jie Pang, Songqi HeJournal of Cancer 2022 · DOI · OpenAlex

This document serves as a formal correction to the 2021 study investigating the role of miR-30a-3p in liver cancer. While the fundamental scientific conclusions regarding the tumor-suppressive role of miR-30a-3p remain valid, this erratum addresses specific technical errors in the original publication's visual data and clarifies laboratory procedures to ensure scientific transparency.

Background and Problem Addressed

The original research focused on Hepatocellular Carcinoma (HCC), specifically how miR-30a-3p inhibits tumor progression by targeting the Cyclooxygenase-2 (COX-2) pathway. COX-2 is frequently overexpressed in cancers, promoting inflammation and growth. The authors demonstrated that miR-30a-3p binds to COX-2, slowing cancer cell proliferation and metastasis.

This erratum corrects two primary issues:

  1. Image Overlap: An error in Figure 6E where images representing different experimental conditions for cell apoptosis overlapped.
  2. Control Clarification: Clarification on the reuse of GAPDH internal loading controls in Western Blotting (Figure 7I).

Methodology

The study utilized the highly metastatic MHCC-97H human hepatocellular carcinoma cell line. Key techniques included:

  • Apoptosis Assays: Hoechst 33342 and Propidium Iodide (PI) staining were used to quantify cell death.
  • Western Blotting: Protein expression levels were measured using a "two-gel" approach. Due to similar molecular weights of target proteins (e.g., GAPDH at 37kD and Caspase-3 at 32kD), samples were run on parallel gels under identical conditions, using a single GAPDH incubation as a consistent internal control across both sets of data.

Key Results and Corrections

Induction of Apoptosis

The corrected Figure 6E demonstrates that miR-30a-3p significantly induces apoptosis in MHCC-97H cells. Importantly, the pro-apoptotic effect is attenuated when COX-2 is overexpressed (the "COX-2 UP" group), confirming that COX-2 is a direct functional target of the microRNA.

Figure 6E: Corrected apoptosis assay showing miR-30a-3p induces cell death, which is reversed by COX-2 overexpression.

The updated Western Blot in Figure 7I illustrates the impact of the miR-30a-3p/COX-2 axis on metastasis markers. miR-30a-3p increases the expression of E-cadherin (promoting cell adhesion) while decreasing the levels of matrix metalloproteinases MMP2 and MMP9 (enzymes that facilitate migration). These effects are reversed upon restoration of COX-2 levels.

Figure 7I: Corrected Western Blot showing protein expression changes in E-cadherin, MMP9, and MMP2.

Conclusion

The corrections provided in this erratum ensure the integrity of the visual evidence supporting the original study's findings. The data consistently shows that miR-30a-3p acts as a tumor suppressor in HCC by directly targeting and inhibiting the COX-2 signaling pathway. This clarification maintains the high standards of transparency required for reproducible cancer research.

Summary updated

Abstract

[This corrects the article DOI: 10.7150/jca.52298.].
BibTeX
@article{yang2022microrna,
  author = {Xuemei Yang and Jialing Sun and Haitao Sun and Bin Wen and MingJia Zhang and HaiYan An and Weicong Chen and Wenting Zhao and Xiaodan Zhong and Chunyu He and Jie Pang and Songqi He},
  title = {{MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2: Erratum}},
  journal = {Journal of Cancer},
  year = {2022},
  doi = {10.7150/jca.78550},
}
Figure